The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ceesay Abraham since 2022.
This trader's CIK number is 1722140.
At the time of last reporting, Ceesay Abraham was the Chief Executive Officer of Rapport Therapeutics, Inc.. (stock ticker symbol RAPP).
Also see all insider trading activities at Rapport Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | CERE | 0 | $0 | 96,056 | $3,255,046 | 96,056 | $1,265,054 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | PCRX | 0 | $0 | 2,354 | $64,005 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RAPP | 0 | $0 | 76,420 | $2,035,064 | 0 | $0 |
1. Cerevel Therapeutics Holdings, Inc. (CERE)
2. Pacira Biosciences, Inc. (PCRX)
3. Rapport Therapeutics, Inc. (RAPP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-08-22 | CERE | Sale | 9,605 | 32.50 | 312,162 |
| 2022-08-22 | CERE | Option Ex | 9,605 | 13.17 | 126,497 |
| 2022-08-22 | CERE | Sale | 9,605 | 32.50 | 312,162 |
| 2022-08-22 | CERE | Option Ex | 9,605 | 13.17 | 126,497 |
| 2022-08-22 | CERE | Sale | 9,605 | 32.50 | 312,162 |
| 2022-08-22 | CERE | Option Ex | 9,605 | 13.17 | 126,497 |
| 2022-08-15 | CERE | Option Ex | 9,606 | 13.17 | 126,511 |
| 2022-08-15 | CERE | Sale | 9,606 | 34.12 | 327,756 |
| 2022-08-05 | CERE | Option Ex | 38,424 | 13.17 | 506,044 |
| 2022-08-05 | CERE | Sale | 38,424 | 32.50 | 1,248,780 |
| 2022-08-08 | CERE | Option Ex | 19,211 | 13.17 | 253,008 |
| 2022-08-08 | CERE | Sale | 19,211 | 38.62 | 742,024 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-04 | PCRX | Sale | 2,354 | 27.19 | 64,005 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-17 | RAPP | Sale | 76,420 | 26.63 | 2,035,064 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ceesay Abraham (Chief Executive Officer of Rapport Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.